Skip to main content
Equibles

NewEdge Advisors, LLC

Position in BDTX — Black Diamond Therapeutics, Inc.

CIK 1633516 NEW ORLEANS, LA
Back to BDTX Full portfolio

Position in BDTX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$6,475
-$6,566 QoQ
Shares Held
3,500
-42.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 96 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in BDTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $47,755,733 across 102 Biotechnology names. BDTX ranks #66 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 18,435 $9,157,217
2 REGN
Regeneron Pharmaceuticals, Inc.
 11,911 $7,426,984
3 NUVB
Nuvation Bio Inc.
 1,231,733 $6,996,243
4 INCY
Incyte Corp
 34,605 $3,922,822
5 PHAT
Phathom Pharmaceuticals, Inc.
 203,962 $2,212,987
6 EXEL
Exelixis, Inc.
 32,532 $1,770,066
7 BMRN
Biomarin Pharmaceutical Inc
 27,287 $1,561,362
8 RPRX
Royalty Pharma plc
 21,597 $1,210,943

All Filings in BDTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,475 3,500
2026-03-31 $13,041 6,123
2025-09-30 $64 17
2025-06-30 $42 17
2025-03-31 $26 17
2024-12-31 $36 17
2024-09-30 $73 17
2024-06-30 $79 17
2024-03-31 $86 17
2023-12-31 $47 17
2023-09-30 $48 17
2023-06-30 $85 17
2023-03-31 $32 17
2022-12-31 $203 113